GCN5-mediated regulation of pathological cardiac hypertrophy via activation of the TAK1-JNK/p38 signaling pathway

Jia Li(Union Hospital), Yaling Han(Northern Hospital)

Cell Death and Disease

April 30, 2022

10.1038/s41419-022-04881-y

Cited by 35

Related Papers

MiR-221-3p targets Hif-1α to inhibit angiogenesis in heart failure

|Laboratory Investigation|2020|52

The novel intracellular protein CREG inhibits hepatic steatosis, obesity, and insulin resistance

|Hepatology|2017|38

The CREG1-FBXO27-LAMP2 axis alleviates diabetic cardiomyopathy by promoting autophagy in cardiomyocytes

|Experimental & Molecular Medicine|2023|34

Up-Regulation of CREG Expression by the Transcription Factor GATA1 Inhibits High Glucose- and High Palmitate-Induced Apoptosis in Human Umbilical Vein Endothelial Cells

|PLoS ONE|2016|17

AMPKα2 controls the anti-atherosclerotic effects of fish oils by modulating the SUMOylation of GPR120

|Nature Communications|2022|13